Vivoo
Vivoo is a San Francisco-based consumer health company that sells smartphone-analyzed at-home urine test kits and personalized nutrition recommendations via subscription, serving wellness and women's health consumers across 100+ countries.
- Company typePrivate
- Founded2017
- HeadquartersSan Francisco, United States
- Headcount51–100
- GTM typeB2C
- OfferingHardware or Manufacturing
What Vivoo does
Vivoo is a privately held consumer health technology company founded in 2017 and headquartered in San Francisco, with operational roots in Turkey. The company builds smartphone-based urine test kits that use proprietary machine learning image processing to analyze test strips and deliver personalized wellness insights within 90 seconds. Its product portfolio spans a general Wellness Test covering eight parameters (water, pH, ketones, calcium, magnesium, vitamin C, sodium, oxidative stress) and a women's health line (UTI, ovulation, fertility, vaginal pH tests) marketed under the HerCheck sub-brand. The company claims a 99.62% validated accuracy rate on its image processing pipeline and layers a recommendation engine built on 7,500+ scientific references to translate biomarker data into dietitian-authored dietary and lifestyle guidance via an AI assistant called Welly.
Vivoo generates revenue through three streams: subscription-based test kit plans (monthly, 3-month, and 6-month cadences), planned hardware sales of its CES 2026-launched Smart Toilet optical-sensor device ($99-$129), and a B2B wholesale partnership program covering 150+ partners across 30+ countries. Go-to-market combines direct-to-consumer e-commerce through vivoo.io, the iOS and Android apps, Amazon marketplace worldwide, and physical retail at Target, CVS, Sam's Club, and Walmart in the USA. Distribution is augmented by healthcare provider endorsements, an affiliate program, content marketing across an extensive blog, and active social channels. The company has also entered Japan through a September 2024 partnership with Otsuka Pharmaceutical, mediated by its US-based Vivosens Inc. entity.
The company has raised approximately $22M across six disclosed rounds from 2018 through 2024, with Draper Associates as the consistent lead investor (most recently a $13M round in July 2024 with participation from Otsuka Holdings and Halogen Ventures). Reported scale includes 500,000+ users, 3M+ tests sold, and presence in 100+ countries. Leadership consists of three co-founders — Miray Tayfun (CEO), Gozde Buyukacaroglu (COO), and George Radman (CFO) — alongside a Head of Wellness and an in-house ML/R&D bench. Forward product roadmaps include the FlowPad smart menstrual pad and continued evolution of the Smart Toilet category.
Vivoo firmographics
Firmographics- Name
- Vivoo
- Legal name
- Vivoo
- Website
- https://vivoo.io
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Vivoo is a San Francisco-based consumer health company that sells smartphone-analyzed at-home urine test kits and personalized nutrition recommendations via subscription, serving wellness and women's health consumers across 100+ countries.
- Ownership category
- akta.pro rank
Vivoo industry classification
Industry- Product category
- At-home health diagnostics / wellness testing
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
- akta.pro secondary industries
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ)
Keywords
Where Vivoo is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vivoo business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations
Revenue model
- Subscription-based Test Kits: Recurring subscription model with monthly, 3-month, and 6-month plans. Customers receive regular shipments of urine test strips (Wellness, UTI, Ovulation, Fertility, Vaginal pH tests) with app access included
- Smart Toilet Hardware Sales: One-time hardware purchase of Smart Toilet device ($99-$129) with optional monthly app subscription ($2.99-$5.99/month)
- B2B Wholesale & Partnerships: Wholesale distribution through retail partners (Target, CVS, Sam's Club, Walmart) and B2B partnerships with fitness studios, healthcare providers, and wellness businesses
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Wellness Test 6-Month Plan |
| Subscription | Multi-year contract | Wellness Test 3-Month Plan |
| Subscription | Monthly | Wellness Test Monthly |
| Unit Pricing | Pay-as-you-go | Wellness Test One-Time |
| Subscription | Monthly | UTI Test Subscription |
| Subscription | Monthly | Ovulation Test |
| Subscription | Monthly | Vaginal pH Test |
| Subscription | Monthly | HerCheck Intimate Duo |
| Subscription | Monthly | HerCheck Cycle Duo |
| Subscription | Monthly | HerCheck Complete Kit |
| One time/ perpetual license | Pay-as-you-go | Smart Toilet Early Bird |
| One time/ perpetual license | Pay-as-you-go | Smart Toilet Standard |
| Unit Pricing | Pay-as-you-go | FlowPad Smart Menstrual Pad |
Go-to-market motion1 record
Distribution channels7 records
Marketing channels7 records
Vivoo product offering
Product offeringCore offering
Vivoo sells at-home urine-based wellness and reproductive health test strips that are analyzed through a companion smartphone app using proprietary machine-learning image processing. Results feed a personalized nutrition and lifestyle recommendation engine, supported by an AI assistant (Welly) and integration with Apple Health and Google Fit. The product line also includes a Smart Toilet optical hydration sensor and a FlowPad microfluidic smart menstrual pad for women's biomarker monitoring.
Differentiator
Problem solved
Functional benefit
Brands
- HerCheck: Women's health testing collection including Intimate Duo (vaginal pH + UTI), Cycle Duo (ovulation + fertility), and Complete Kit for comprehensive reproductive and hormonal health tracking.
Products and services
- Vivoo Wellness Test
Quantifiable outcome
- 99.62% accuracy rate based on analysis of 2,618 test strips
- +5 more outcomes
Companies that use Vivoo
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles3 records
Vivoo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability6 records
Feature5 records
Vivoo partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered major and core.
- Otsuka Pharmaceutical Co., Ltd.majorJapan-based Otsuka Pharmaceutical partnered with Vivosens Inc. (Vivoo's US entity) to launch the Vivoo nutrition tracking service in Japan in September 2024. The service uses AI and image recognition to provide personalized nutritional insights from at-home urine tests, marking Vivoo's entry into the Japanese market.
- Vivosens Inc.coreVivosens Inc. is the US-based entity partnered with Otsuka Pharmaceutical to launch Vivoo nutrition tracking service in Japan. This appears to be an exclusive licensing/partnership arrangement for the Japanese market.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
Vivoo competitors and assessment
Company assessmentDirect peers
- Eli Health: Eli Health offers at-home saliva and urine-based hormone and wellness tests paired with a smartphone app, directly competing with Vivoo in the connected at-home diagnostics and women's health space.
- Levels Health: Levels is a subscription-based metabolic health tracker using continuous glucose monitoring plus an AI app, competing with Vivoo for the same health-conscious consumer wallet with real-time, app-delivered wellness insights.
- Cue Health: Cue Health provides connected at-home diagnostic readers and test cartridges for a range of biomarkers, making it a direct competitor in the connected at-home diagnostics category Vivoo targets.
- Modern Fertility (by Ro): Modern Fertility offers at-home hormone testing for women with app-based personalized insights, directly comparable to Vivoo's fertility/ovulation/pH product line and women's health positioning.
- iHealth Labs: iHealth Labs makes a broad line of connected at-home health monitoring devices (glucose meters, blood pressure, COVID tests) sold through retail and online, overlapping Vivoo's at-home diagnostic reader + retail distribution model.
Broad incumbents
- Clearblue: Clearblue is the established global incumbent in ovulation, fertility, and pregnancy test strips, directly overlapping Vivoo's ovulation and fertility SKUs with a much larger retail footprint and brand recognition.
- Oura: Oura sells the Oura Ring, a consumer wellness wearable with an AI-powered app, competing with Vivoo for health-conscious consumers seeking continuous, app-delivered wellness data.
- Whoop: Whoop offers a subscription-based wearable and app for fitness, recovery, and wellness tracking, targeting the same wellness-driven consumer segment as Vivoo with a much larger brand and funding base.
Emerging players
- Natural Cycles: Natural Cycles is an FDA-cleared digital fertility tracking app with a connected thermometer, comparable to Vivoo in the women's reproductive health + app-driven wellness space, though based on temperature rather than urine biomarkers.
- Stelo (Dexcom): Stelo, the consumer glucose biosensor by Dexcom, is a subscription-based at-home metabolic health monitor that competes with Vivoo for health-conscious consumers who want app-delivered, real-time biomarker insights.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Vivoo social profiles
Digital presenceVivoo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vivoo leadership team
Management profileNumber of profiles
Profiles9 records
Vivoo funding detail
Funding detailFunding overview
Funding rounds6 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vivoo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vivoo
What does Vivoo do?
Vivoo sells at-home urine-based wellness and reproductive health test strips that are analyzed through a companion smartphone app using proprietary machine-learning image processing. Results feed a personalized nutrition and lifestyle recommendation engine, supported by an AI assistant (Welly) and integration with Apple Health and Google Fit. The product line also includes a Smart Toilet optical hydration sensor and a FlowPad microfluidic smart menstrual pad for women's biomarker monitoring.
Is Vivoo a public or private company?
Vivoo is a private company. It is classified as venture growth investor backed and is currently operating.
When was Vivoo founded?
Vivoo was founded in 2017. It employs 51 to 100 people.
Where is Vivoo based?
Vivoo is headquartered in San Francisco, United States, in the North America region.
How does Vivoo make money?
Three revenue lines are on record. Subscription-based Test Kits are the primary driver. The others are smart Toilet Hardware Sales and B2B Wholesale & Partnerships.
Who are Vivoo's main competitors?
Direct peers on record are Eli Health, Levels Health, Cue Health, Modern Fertility (by Ro) and iHealth Labs. Broad incumbents are Clearblue, Oura and Whoop. Emerging players are Natural Cycles and Stelo (Dexcom).
Does Vivoo have an API?
No public API is recorded for Vivoo.
What industry is Vivoo in?
Vivoo's product category is At-home health diagnostics / wellness testing. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument). Its NAICS code is 325413 and its SIC code is 2835.